Glooko integrates with Roche Accu-Chek CGM
By HME News Staff
Updated 9:08 AM CDT, Wed March 11, 2026
GOTHENBURG, Sweden – Glooko has announced that the Glooko platform will integrate with the Roche Accu-Chek SmartGuide continuous glucose monitor (CGM) solution across select European countries, subject to local availability. The company says this integration will enable people using the Accu-Chek SmartGuide CGM to bring their data into Glooko, alongside data from other connected diabetes and health monitoring devices. It says this can reduce the administrative burden for health care teams, allow for the viewing of key insights in one place, and support effective collaboration between patient visits. “Diabetes data is only powerful when it’s accessible, connected and easy to act on,” said Mike Alvarez, CEO of Glooko. “By integrating Roche’s Accu-Chek SmartGuide CGM into the Glooko platform, we’re expanding choice for people with diabetes and clinicians. Now, they can bring Accu-Chek SmartGuide CGM data together with the rest of the patient’s health and medication therapy context, in a single experience designed to support better, more informed decisions.” Glooko is the first diabetes data management platform outside of Roche’s ecosystem that will integrate with the Accu-Chek SmartGuide CGM.
Comments